Cell and Gene Challenges with AGC Biologics

Georgi Makin
20 March 2023
Cell Therapy
Gene Therapy
Regulatory & Standards
Supply Chain
Viral/Non-Viral Vectors
Maggie Chen, Head of Manufacturing at AGC Biologics, explores the challenges within the cell and gene therapy landscape. 

In this interview, Maggie initially considers challenges associated with the cost of goods and supply chain, before discussing how standardization will benefit viral vector development.

Maggie goes on to address analytics and bad data as rate limiting factors to the progression of the field, and how a combination of different approaches may be what’s needed to realize the future of cell and gene therapies, before explaining what we might have to look forward to from AGC Biologics.

This interview has been produced in partnership with AGC Biologics and was recorded at Advanced Therapies Week 2023.